Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, provides drug discovery and development services in Japan and internationally. It offers pre-clinical laboratory services, such as good laboratory practice inspections; general and specific toxicity studies; pathological examinations; PK/PD of biopharmaceuticals, immunotoxicity tests, and antibody production; reproductive and developmental toxicity studies; pharmacology and pharmacological efficacy studies; and imaging services. The company also engages in the establishment and validation of analytical methods, analysis of biological samples, and calculation of pharmacokinetic parameters; and provides absorption, distribution, metabolism, and excretion studies using radioisotope-labeled compounds. In addition, it provides site management organization services for clinical trials; clinical contract research organization services; and translational research services, including research and development of nasal delivery systems, nucleic acid adjuvants, and regenerative medicines. The company was founded in 1957 and is headquartered in Tokyo, Japan.
What is Shin Nippon Biomedical Laboratories stock price today?▼
The current price of SBLOF is $9.16 USD — it has decreased by -12.59% in the past 24 hours. Watch Shin Nippon Biomedical Laboratories stock price performance more closely on the chart.
What is Shin Nippon Biomedical Laboratories stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Shin Nippon Biomedical Laboratories stocks are traded under the ticker SBLOF.
What is Shin Nippon Biomedical Laboratories market cap?▼
Today Shin Nippon Biomedical Laboratories has the market capitalization of 381.38M
When is the next Shin Nippon Biomedical Laboratories earnings date?▼
Shin Nippon Biomedical Laboratories is going to release the next earnings report on May 11, 2026.
What were Shin Nippon Biomedical Laboratories earnings last quarter?▼
SBLOF earnings for the last quarter are 0.19 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Shin Nippon Biomedical Laboratories revenue for the last year?▼
Shin Nippon Biomedical Laboratories revenue for the last year amounts to 436.13M USD.
What is Shin Nippon Biomedical Laboratories net income for the last year?▼
SBLOF net income for the last year is 66.1M USD.
Does Shin Nippon Biomedical Laboratories pay dividends?▼
Yes, SBLOF dividends are paid semi-annual. The last dividend per share was 0.19 USD. As of today, Dividend Yield (FWD)% is 1.48%.
When did Shin Nippon Biomedical Laboratories complete a stock split?▼
Shin Nippon Biomedical Laboratories has not had any recent stock splits.
Where is Shin Nippon Biomedical Laboratories headquartered?▼
Shin Nippon Biomedical Laboratories is headquartered in Kagoshima, JP.